METABOLISM OF ANTI-TUMOUR AGENT 5-(1-AZIRIDINYL)-2,4-DINITROBENZAMIDE (CB 1954)

被引：20

作者：

JARMAN, M ^{[1
]}

MELZACK, DH ^{[1
]}

ROSS, WCJ ^{[1
]}

机构：

[1] ROY CANC HOSP,INST CANC RES,CHESTER BEATTY RES INST,SUTTON,SURREY,ENGLAND

来源：

BIOCHEMICAL PHARMACOLOGY | 1976年 / 25卷 / 22期

关键词：

D O I：

10.1016/0006-2952(76)90451-2

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：2475 / 2478

页数：4

共 50 条

[1] METABOLISM OF ANTI-TUMOUR AGENT 1(1-AZIRIDINYL)-2,4-DINITROBENZENE (CB 1837)
CONNORS, TA
HICKMAN, JA
JARMAN, M
MELZACK, DH
ROSS, WCJ
BIOCHEMICAL PHARMACOLOGY, 1975, 24 (18) : 1665 - 1670
[2] SELECTIVE-INHIBITION OF RIBONUCLEOTIDE REDUCTASE BY THE MONO-FUNCTIONAL ALKYLATING AGENT 5(1-AZIRIDINYL)-2,4-DINITROBENZAMIDE (CB-1954)
TISDALE, MJ
HABBERFIELD, AD
BIOCHEMICAL PHARMACOLOGY, 1980, 29 (20) : 2845 - 2853
[3] STUDIES ON MECHANISM OF ACTION OF 5-AZIRIDINYL-2,4-DINITROBENZAMIDE (CB 1954), A SELECTIVE INHIBITOR OF WALKER TUMOUR
CONNORS, TA
MELZACK, DH
INTERNATIONAL JOURNAL OF CANCER, 1971, 7 (01) : 86 - &
[4] A SPECTROPHOTOMETRIC METHOD FOR ESTIMATION OF CARCINOSTATIC AGENT, 5-AZIRIDINO-2,4-DINITROBENZAMIDE (CB 1954), IN BIOLOGICAL FLUIDS
ROSS, WCJ
BIOCHEMICAL PHARMACOLOGY, 1969, 18 (11) : 2683 - &
[5] Role of redox cycling and activation by DT-diaphorase in the cytotoxicity of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB-1954) and its analogs
Miskiniene, V
Sergediene, E
Nemeikaite, A
Segura-Aguilar, J
Cenas, N
CANCER LETTERS, 1999, 146 (02) : 217 - 222
[6] Crystal structure of human DT-diaphorase: A model for interaction with the cytotoxic prodrug 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB1954)
Skelly, JV
Sanderson, MR
Suter, DA
Baumann, U
Read, MA
Gregory, DSJ
Bennett, M
Hobbs, SM
Neidle, S
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (21) : 4325 - 4330
[7] THE BIOACTIVATION OF 5-(AZIRIDIN-1-YL)-2,4-DINITROBENZAMIDE (CB1954) .2. A COMPARISON OF AN ESCHERICHIA-COLI NITROREDUCTASE AND WALKER DT DIAPHORASE
KNOX, RJ
FRIEDLOS, F
SHERWOOD, RF
MELTON, RG
ANLEZARK, GM
BIOCHEMICAL PHARMACOLOGY, 1992, 44 (12) : 2297 - 2301
[8] Pharmacokinetics and metabolism of the nitrogen mustard bioreductive drug 5-[N,N-bis(2-chloroethyl)amino]-2,4-dinitrobenzamide (SN 23862) and the corresponding aziridine (CB 1954) in KHT tumour-bearing mice
Kestell, P
Pruijn, FB
Siim, BG
Palmer, BD
Wilson, WR
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2000, 46 (05) : 365 - 374
[9] Pharmacokinetics and metabolism of the nitrogen mustard bioreductive drug 5-[N,N-bis(2-chloroethyl)amino]-2,4-dinitrobenzamide (SN 23862) and the corresponding aziridine (CB 1954) in KHT tumour-bearing mice
Philip Kestell
Frederik B. Pruijn
Bronwyn G. Siim
Brian D. Palmer
William R. Wilson
Cancer Chemotherapy and Pharmacology, 2000, 46 : 365 - 374
[10] THE DIFFERENCES IN KINETICS OF RAT AND HUMAN DT DIAPHORASE RESULT IN A DIFFERENTIAL SENSITIVITY OF DERIVED CELL-LINES TO CB-1954 (5-(AZIRIDIN-1-YL)-2,4-DINITROBENZAMIDE)
BOLAND, MP
KNOX, RJ
ROBERTS, JJ
BIOCHEMICAL PHARMACOLOGY, 1991, 41 (6-7) : 867 - 875

← 1 2 3 4 5 →